High-density lipoprotein subfractions in normolipidemic individuals without clinical atherosclerosis lipoprotein subfractions in an adult population

Journal of Clinical Laboratory Analysis

Volumn 20, Issue 3, 2006, Pages 113-117

  Sodré, Fabio L ^a   Castanho, Vera S ^a   Castilho, Lucia N ^a   De Barros Mazon, Silvia ^a   De Faria, Eliana Cotta ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE   (Brazil)

Author keywords

Age; Cholesterol; High density lipoprotein subfractions; Sex; Triglycerides

Indexed keywords

APOLIPOPROTEIN; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BRAZIL; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; ENZYME CHEMISTRY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL2; LIPOPROTEINS, HDL3; MALE; MIDDLE AGED; QUESTIONNAIRES; REFERENCE VALUES; TRIGLYCERIDES;

EID: 33744787632     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20111     Document Type: Article

References (38)

1. Mansur AP, Favarato D, Souza MFM, et al. Trends in death from circulatory diseases in Brazil between 1979 and 1996. Arq Bras Cardiol 2001;76:497-510.
2. Secretaria Municipal da Sau̇de da Cidade de Campinas: http://www.campinas.sp.gov.br/saude/dados/mortalidade/2.htm.
3. Mille NE, Hammet F, Salttissi S, et al. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J 1981;282:1741-1743.
4. Castelli WP. Lipids, risk factors and ischemic heart disease. Atherosclerosis 1996;124(Suppl):S1-S9.
5. Kannel WB. Contributions of the Framingham Study to the conquest of coronary artery disease. Am J Cardiol 1988;62:1109-1112.
6. Kannel WB. Metabolic Risk Factors for Coronary Heart Disease in Women: Perspective from the Framinghan Study. Am Heart J 1987;114:413-419.
7. Giannini SD. Lipoproteinas como Fatores de Risco em Mulheres. Rev Soc Cardiol Estado de São Paulo 1996;6:681-689.
8. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non contraceptive estrogen use in women: Results from the Lipid Research Clinics Program Follow-Up Study. Circulation 1987;75:1102-1109.
9. Godsland IF, Wynn V, Crook D, Miller EN. Sex, plasma lipoprotein, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987;114:1467-1503.
10. Nye ER, Carlson K, Kirstein P, Rösser S. Changes in high-density lipoprotein subfractions and other lipoprotein induced by exercise. Clinica Chimica Acta 1981;113:51-57.
11. Ballantyne FC, Clark RS, Simpson HS, Ballantyne D. High-density and low density subfractions in survivors of myocardial infarction and in control subjects. Metabolism 1982;31:433-437.
12. Marques-Vidal P, Ruidavets JB, Cambou JP, Cambien F, Chap H, Perret B. Distribution, fatty acid composition and apolipoprotein A-I immunoreactivity of high density lipoprotein subfractions in myocardial infarction. Atherosclerosis 1995;112:29-38.
13. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and risk of myocardial infarction. N Engl J Medicine 1991;325:373-381.
14. Sich D, Saïdi Y, Giral P, et al. Hiperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein 2 levels and decreased hepatic lipase activity. Metabolism 1998;47:965-973.
15. Laakso M, Pyöralä K. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes. Metabolism 1990;39:117-122.
16. Atger V, Giral P, Simon A, et al. High-density lipoprotein subtractions as markers of early atherosclerosis. Am J Cardiol 1995;75:127-131.
17. Ohta T, Saku K, Takata K, Nagata N, Maung KK, Matsuda I. Fractional esterification rate of cholesterol in high-density lipoprotein (HDL) can predict the particle size of low density lipoprotein and HDL in patients with coronary heart disease. Atherosclerosis 1997;135:205-212.
18. Mowat BF, Skinner ER, Wilson HM, Leng GC, Fowkes FGR, Horrobin D. Alterations in plasma lipids, lipoproteins and high-density lipoprotein subfractions in peripheral arterial disease. Atherosclerosis 1997;1131:161-166.
19. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 2001;285:2486-2497.
20. Eyre J, Hammett F, Miller NE. A micro-method for the rapid ultracentrifugal separation of human plasma high-density lipoprotein subfractions, HDL2 and HDL3. Clin Chim Acta 1981;114:225-231.
21. Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distribution in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1980;60:427-439.
22. Meilahn EN, Kuller LH, Matthews KA, Wing RR, Caggiula AW, Stein EA. Potential for increasing high-density lipoprotein cholesterol subfractions HDL2-chol and HDL3-chol, and apoprotein AI among middle-age women. Prev Med 1991;20:462-473.
23. Asseherman H, Gooren LJG, Megens JAJ, Nauta J, Kloosterboer HJ, Eikelboom. Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2-cholesterol. Metabolism 1994;43:935-939.
24. Hartung GH, Reeves RS, Foreyt JP, Patsch W, Gotto AM. Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women. Am J Cardiol 1986;58:148-151.
25. Haffner SM, Stern MP, Hazuda HP, et al. Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non insulin-dependent diabetes mellitus, lipids, and lipoproteins. Diabetes 1987;36:54-59.
26. Haffner SM, Applebaum-Bowden D, Wahl P, et al. Epidemiological correlates of high-density lipoprotein subfractions, apolipoproteins AI, AII and D, and lecithin cholesterol acyl transferase: effects of smoking, alcohol, and adiposity. Arteriosclerosis 1985;5:169-177.
27. Fulton-Keroe DL, Eckel RH, Shetterly SM, Hamman RF. Determinants of total high-density lipoprotein cholesterol and high-density lipoprotein subfraction levels among Hispanic and non-Hispanic white persons with normal glucose tolerance: the San Luis Valley Diabetes Study. J Clin Epidemiol 1992;45:1191-1200.
28. Abbott RD, Wilson PWF, Kannel WB, Castelli WP. High-density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the Framingham Study. Arteriosclerosis 1988;8:207-211.
29. 3) in non-insulin-dependent diabetics with coronary artery disease. J Diabetes Complications 2001;15:265-269.
30. Drexel H, Amann FW, Rentsch K, et al. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 1992;70:436-440.
31. Sakuma N, Yoshikawa M, Hibino T, et al. HDL3 exerts a more powerful antiperoxidative and protective effect against peroxidative modification of LDL than HDL2 does. J Nutr Sci Vitaminol (Tokyo) 2002;48:278-282.
32. Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003;23:1881-1888.
33. 3 cholesterol and apolipoprotein A-I and B in healthy men and women and associations with age, gender, hormonal status and sex hormone use: the Stanford Five City Project. Prev Med 2000;31:335-345.
34. Shepherd J, Packard CJ, Stewart JM, Vallance BD, Lawrie TDV, Morgan HG. The relationship between the cholesterol content and subfraction distribution of plasma high-density lipoproteins. Clin Chim Acta 1980;10:57-62.
35. Sunami Y, Motoyama M, Kinoshita F, et al. Effects of low-intensity aerobic training on the high-density lipoprotein cholesterol in healthy elderly subjects. Metabolism 1999;48:984-988.
36. Spat-Douglas T, Keyser ER. Exercise intensity: its effect on the high-density lipoprotein profile. Arch Phys Med Rehabil 1999;80:691-695.
37. 3 cholesterol. Atherosclerosis 2000;152:503-510.
38. Legato MJ. Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy. Am J Cardiol 2000;86(Suppl):15L-18L.